ZACKSยท2025-08-07 01:36Core Insights - Axon Enterprise (AXON) and Palantir Technologies (PLTR) have experienced significant stock price increases, with AXON up over 40% year-to-date and PLTR surging more than 130% [1][2] - Both companies have reported strong Q2 results, driven by increased public safety and defense spending [3][8] Axon Enterprise Highlights - Axon reported Q2 sales of $668.54 million, a nearly 33% year-over-year increase, surpassing estimates of $642.98 million by 4% [3] - This marks the 14th consecutive quarter of revenue growth above 25%, with broad demand across its portfolio, including AI services and drones [4] - Q2 earnings per share (EPS) were $2.12, exceeding expectations of $1.54 by 37% and up 76% from $1.20 in the prior period [5] - Axon has exceeded the Zacks EPS Consensus for 33 consecutive quarters, with an average earnings surprise of 25.87% over the last four quarters [5] Palantir Technologies Highlights - Palantir achieved its first billion-dollar quarter with Q2 sales of $1 billion, a 48% increase from $678.13 million a year ago, driven by strong demand for its AI platform [8] - The company secured a $10 billion contract with the U.S. Army, contributing to its growth [8] - Q2 EPS was $0.16, up from $0.09 in the comparative quarter and exceeding expectations of $0.14 [9] - Palantir has exceeded the Zacks EPS Consensus for 11 consecutive quarters, with an average earnings surprise of 13.17% over the last four quarters [10] Full-Year Guidance Updates - Axon raised its fiscal 2025 revenue guidance to $2.65-$2.73 billion, up from $2.6-$2.7 billion, and adjusted EBITDA guidance to $665-$685 million [12] - Palantir increased its FY25 revenue forecast to $4.142 billion-$4.15 billion, up from $3.89 billion-$3.9 billion, with commercial revenue expected to exceed $1 billion [13] Valuation Insights - Axon trades at a price-to-sales (P/S) ratio of 25X, while Palantir's P/S ratio is significantly higher at 104X, indicating Axon may offer better value at current levels [15] - Axon's profitability and earnings estimate revisions suggest it is a more sound investment compared to Palantir, which may not offer much fundamental value after its recent rally [18]